Journal of Colloid and Interface Science,
Journal Year:
2023,
Volume and Issue:
646, P. 370 - 380
Published: April 28, 2023
In
recent
years,
small
interfering
RNA
(siRNA)
has
been
widely
used
in
the
treatment
of
human
diseases,
especially
tumors,
and
shown
great
appeal.
However,
clinical
application
siRNA
faces
several
challenges.
Insufficient
efficacy,
poor
bioavailability,
stability,
lack
responsiveness
to
a
single
therapy
are
main
problems
affecting
tumor
therapy.
Here,
we
designed
cell-penetrating
peptide
(CPP)-modified
metal
organic
framework
nanoplatform
(named
PEG-CPP33@ORI@survivin
siRNA@ZIF-90,
PEG-CPP33@NPs)
for
targeted
co-delivery
oridonin
(ORI),
natural
anti-tumor
active
ingredient)
survivin
vivo.
This
can
improve
stability
bioavailability
efficacy
monotherapy.
The
high
drug-loading
capacity
pH-sensitive
properties
zeolite
imidazolides
endowed
PEG-CPP33@NPs
with
lysosomal
escape
abilities.
Polyethylene
glycol
(PEG)-conjugated
CPP
(PEG-CPP33)
coating
significantly
improved
uptake
vitro
results
showed
that
ORI
greatly
enhanced
effect
PEG-CPP33@NPs,
demonstrating
synergistic
between
siRNA.
summary,
novel
nanobiological
platform
loaded
presented
herein
advantages
cancer
therapy,
provides
an
attractive
strategy
chemotherapy
gene
Molecules,
Journal Year:
2023,
Volume and Issue:
28(9), P. 3916 - 3916
Published: May 5, 2023
The
development
of
new
functional
materials
based
on
metal-organic
frameworks
(MOFs)
for
adsorption
and
catalytic
applications
is
one
the
promising
trends
modern
science.
Zr-based
MOFs,
specifically
UiO-66,
are
considered
as
supports
metallic
catalysts
5-hydroxymethylfurfural
platform
molecule
reduction
into
valuable
products.
present
work
focused
effect
NH2
modification
UiO-66
its
structure
properties.
samples
were
prepared
by
a
solvothermal
method.
obtained
was
studied
X-ray
diffraction,
IR
spectroscopy,
UV-visible
low-temperature
nitrogen
adsorption.
Basic
properties
investigated
HCl
CH3COOH
adsorption,
electrokinetic
electrophoretic
light
scattering.
UiO-66-NH2
with
different
contents
aminoterephthalate
linkers
successfully
prepared.
A
gradual
decrease
in
specific
surface
area
fraction
micropores
diameter
~0.9
nm
observed
an
increase
content.
proportional
total
number
basic
sites
established
content
up
to
75%.
At
same
time,
noticeable
their
strength
higher
observed.
Journal of Colloid and Interface Science,
Journal Year:
2023,
Volume and Issue:
646, P. 370 - 380
Published: April 28, 2023
In
recent
years,
small
interfering
RNA
(siRNA)
has
been
widely
used
in
the
treatment
of
human
diseases,
especially
tumors,
and
shown
great
appeal.
However,
clinical
application
siRNA
faces
several
challenges.
Insufficient
efficacy,
poor
bioavailability,
stability,
lack
responsiveness
to
a
single
therapy
are
main
problems
affecting
tumor
therapy.
Here,
we
designed
cell-penetrating
peptide
(CPP)-modified
metal
organic
framework
nanoplatform
(named
PEG-CPP33@ORI@survivin
siRNA@ZIF-90,
PEG-CPP33@NPs)
for
targeted
co-delivery
oridonin
(ORI),
natural
anti-tumor
active
ingredient)
survivin
vivo.
This
can
improve
stability
bioavailability
efficacy
monotherapy.
The
high
drug-loading
capacity
pH-sensitive
properties
zeolite
imidazolides
endowed
PEG-CPP33@NPs
with
lysosomal
escape
abilities.
Polyethylene
glycol
(PEG)-conjugated
CPP
(PEG-CPP33)
coating
significantly
improved
uptake
vitro
results
showed
that
ORI
greatly
enhanced
effect
PEG-CPP33@NPs,
demonstrating
synergistic
between
siRNA.
summary,
novel
nanobiological
platform
loaded
presented
herein
advantages
cancer
therapy,
provides
an
attractive
strategy
chemotherapy
gene